Browsing by Author "Ozyiğit, Gokhan"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Review of Current Status of Radiotherapy Facilities and Assessment of Required Time for Radiotherapy Delivery Workflow in Turkey: On Behalf of Turkish Society for Radiation Oncology(2015) Akman, Fadime; Onal, Cem; Kamer, Serra; Agaoglu, Fulya; Guney, Yildiz; Hicsonmez, Ayse; Koc, Mehmet; Oksuz, Didem C.; Ozyiğit, Gokhan; Ozkok, SerdarThe aim this study is to evaluate current status and workload of radiotherapy (RT) centers in Turkey, by assessing time and staff required during core treatment procedures in patients with different tumor sites. A survey sent via e-mail to all hospitals that are actively treating patients with RT, that aimed expose the details on type of the techniques being used and the time spent for treatment planning and delivery for the different techniques according to different tumor sites. The results were evaluated by several variables, the type of the center (university hospitals or state-run hospitals) and the number of patients treated per year per center (<1000 patients/year treated vs. 000 patients/year treated). The survey was sent to 48 centers and the return rate was 71% (34 centers). Average daily treatment course performed by one physician was 192 per year (range: 41 - 650). Median number of patients treated by a specialist per year was 210 (range: 79 - 650) in the university hospitals and 101 (range: 41 - 167) in the state-run hospitals. Median time spent for treating a patient with 3-dimensional conformal RT (3DCRT) was 4 h, and it was 5 h 45 min for intensity-modulated AT (IMRT). The time spent for all cancer types treated with 3DCRT and IMRT was higher in state-run hospitals compared to university hospitals. With increasing use of newer AT techniques, the time spent for treating patients increases. Besides adequate equipment, sufficient and well-trained staff is required to achieve these newer AT technique benefits for the patients.Item Three Dimensional Conformal Radiotherapy and Androgen Deprivation Therapy in Patients with Clinically Localized Prostate Cancer; Hacettepe University Experience(2015) Ozdemir, Yurday; Akyol, Fadil; Ozyiğit, Gokhan; Hurmuz, Pervin; Onal, Cem; Selek, Ugur; Karabulut, ErdemThe aim of this study into evaluate the treatment results of three dimensional conformal radiotherapy (3DCRT) and androgen deprivation therapy (ADT) in patients with clinically localized prostate cancer (CLPC). Between June 1998 and December 2011, 577 patients with the diagnosis of CLPC were treated. ADT was started 3 months prior to radiotherapy (RT). 3DCRT was delivered to prostate and the seminal vesicles (SV) to a total dose of 70Gy. Additionally, patients with lymph node (LN) positivity received 50.4Gy RT to pelvic LN's. Median follow up time was 65 months. Five-ten years overall survival (OS), cause specific survival (CSS), PSA relapse-free survival (PSA-RFS) and distant metastasis-free survival (DMFS) rates were 92-74%, 97-91%, 77-55% and 94-88%, respectively. OS was negatively affected from LN positivity (p < 0.001). In the subgroup of patients With GS 8, there was no significant difference between < 1 years and 1 years of ADT in terms of CSS, PSA-RFS and DMFS. OS was better in patients with < 1 years of ADT (p = 0.01). Five year OS (p = 0.02), CSS (p = 0.05), PSA-RFS (p = 0.01) and DMFS (p = 0.07) rates were inferior in the high risk group patients that used ADT 1 year. Acute and late RTOG grade III/IV gastrointestinal system toxicity rates were 1.7% and 5% and acute and chronic RTOG grade III/IV genitourinary system toxicity rates were 1.4% and 5%, respectively. 3DCRT and ADT combination is an effective treatment modality with acceptable toxicities in patients with clinically localized prostate cancer.